Screening of Small Molecule Libraries for Identification of a Novel Inhibitor of ADAR1

Screening of Small Molecule Libraries for Identification of a Novel Inhibitor of ADAR1

27th Annual Meeting of the RNA Society

Now Enrolling: The PROSERA Phase 3 study of seralutinib in adults with Pulmonary Arterial Hypertension (PAH).

PROSERA clinical trial: NCT05934526

Learn more about the study